Cancer Blog
- Dr. Robert Nagourney -

IN HER2 (+) BREAST CANCER, THE MOST WIDELY USED TREATMENT MAY NOT BE THE RIGHT ONE FOR YOU

Despite advances in breast cancer management, we must all recognize that every patient is unique and their treatments should be too.

IN LUNG AND BREAST CANCER COMBINED CHEMO-IMMUNOTHERAPY LOOKS BEST, BUT WHICH DRUGS?

With the explosion of immunotherapy in oncology, the checkpoint inhibitors (Pembrolizumab, Nivolumab, Ipililumab, etc.) are being used in...